Breast imaging is a representation or reproduction of a breasts form. It is used in diagnosis of breast-related abnormalities such as blocked milk ducts, fibrocystic breast changes, intraductal papillomas, fibroadenomas, cysts and others. The technology is used by physicians and oncology surgeons in order to perform diagnostis of breast structure, lumps, cells composition and other internal parts of the breast. It includes several technologies and tools for detection, screening, and diagnosis of breast cancer. It is classified as invasive ductal carcinoma, metastatic breast cancer, ductal carcinoma in situ, and inflammatory breast cancer.

According to study, “Global Breast Imaging Market Size study, by technology (ionizing and non-ionizing) and Regional Forecasts 2018-2025” the key companies operating in the global breast imaging market are SonoCine, Inc., Fujifilm Holdings Corporation, Siemens Healthcare, GE Healthcare, Aurora Imaging Technology, Inc., Dilon Technologies, Inc., Philips Healthcare, Hologic, Inc., Gamma Medical Merate S.P.A., CMR Naviscan Corp., Canon Inc., Koninklijke Philips NV., DUNE Medical Devices, Agfa-Gevaert Group.

Based on technology type, breast imaging market is segmented into ionizing technologies, non-ionizing technologies and other breast imaging technologies (electric impedance tomography, Cone-beam Computed Tomography (CBCT) and optical imaging). Ionizing technologies are further sub-segmented into full-field digital mammography, analog mammography, Positron Emission Mammography (PEM), electric impedance tomography, 3D breast tomosynthesis, Molecular Breast Imaging (MBI)/Breast-Specific Gamma (BSGI) and positron emission tomography & computed tomography (PET-CT). 3D tomosynthesis segment is projected to witness highest growth rate owing to its benefits such as higher diagnostics accuracy as compared to other technologies and improved efficiency during the forecast period. Additionally, non-ionizing technologies are further sub-segmented into breast MRI, optical imaging, breast thermography, breast ultrasound, and automated whole-breast ultrasound (AWBU). In addition, based on end-user, market is segmented into hospitals, ambulatory clinics, women’s health center, and breast care clinics.

The breast imaging market is driven by rise in awareness on early detection of breast cancer, followed by increase in aging population, rise in advanced systems for efficient testing & treatment of breast cancer, increase in standard of living and growth in public-private investments, funds, and grants. However, unfavorable reimbursement scenario, side effects of chemo and high cost of breast imaging systems may impact the market. Moreover, miniaturization & technological advancements in breast imaging technologies is a key opportunity for market.

Based on geography, the North-American region dominates the breast imaging market owing to increase in prevalence of breast cancer, unhealthy life style and rise in government initiatives to promote precision medicine in the region. The European and North-American regions are likely to emerge as the fastest growing regions in terms of market share due to increase in investments in healthcare sector and rise in awareness of breast cancer & related issues over the forecast period. In upcoming years, it is expected that future of the market will be bright caused by improvement in healthcare infrastructure, increase in research & development (R&D) for breast cancer, rise in medical tourism, growth in alcohol consumption and rise in geriatric population & increase in per capita income during the forecast period. It is estimated that the market will be reached at US $8.3 billion by 2025.

For more information, click on the link below:

Global Breast Imaging Market

Related Reports:-

Global Breast Imaging Equipment Market Status and Future Forecast 2015-2024

World Breast Imaging Equipment Market Research Report 2024(covering USA, EU, China, South East Asia, Japan and etc)

Contact Us:    

Ken Research

Ankur Gupta, Head Marketing & Communications

Ankur@kenresearch.com

+91 9015378249